Is the development of a new tuberculosis vaccine possible?
Whereas federal expenditure in the United States on the development of an HIV/AIDS vaccine is approximately $250 million, only $25 million is spent on research and development for a malaria vaccine. It is not malaria but tuberculosis (TB) that is the poor relation. Government funds for a vaccine to fight this disease are in single figure millions. Stefan Kaufmann of the Max Planck Institute for Infection Biology examines obstacles in addition to funding that hinder the development of a new TB vaccine.
Related Questions
- Is it possible to combine subsidy programs, such as an Individual Development Account (IDA) Program for down payment assistance with any of the home loans designated for teachers?
- What are some examples of major successes in public/private partnerships when it comes to vaccine development?
- What is the development status of the preventative vaccine candidate?
